These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 25671764)

  • 1. Current treatment practice and outcomes. Report of the hyponatremia registry.
    Greenberg A; Verbalis JG; Amin AN; Burst VR; Chiodo JA; Chiong JR; Dasta JF; Friend KE; Hauptman PJ; Peri A; Sigal SH
    Kidney Int; 2015 Jul; 88(1):167-77. PubMed ID: 25671764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Management of Hyponatremia in Acute Heart Failure: A Report From the Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia (HN Registry).
    Dunlap ME; Hauptman PJ; Amin AN; Chase SL; Chiodo JA; Chiong JR; Dasta JF
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28775063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosing and Treating the Syndrome of Inappropriate Antidiuretic Hormone Secretion.
    Verbalis JG; Greenberg A; Burst V; Haymann JP; Johannsson G; Peri A; Poch E; Chiodo JA; Dave J
    Am J Med; 2016 May; 129(5):537.e9-537.e23. PubMed ID: 26584969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Euvolemic hyponatremia in cancer patients. Report of the Hyponatremia Registry: an observational multicenter international study.
    Burst V; Grundmann F; Kubacki T; Greenberg A; Rudolf D; Salahudeen A; Verbalis J; Grohé C
    Support Care Cancer; 2017 Jul; 25(7):2275-2283. PubMed ID: 28255808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiazide-Associated Hyponatremia, Report of the Hyponatremia Registry: An Observational Multicenter International Study.
    Burst V; Grundmann F; Kubacki T; Greenberg A; Becker I; Rudolf D; Verbalis J
    Am J Nephrol; 2017; 45(5):420-430. PubMed ID: 28419981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of 3% saline vs. conivaptan in achieving hyponatremia treatment goals.
    Dominguez M; Perez JA; Patel CB
    Methodist Debakey Cardiovasc J; 2013; 9(1):49-53. PubMed ID: 23519387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management Strategies and Outcomes for Hyponatremia in Cirrhosis in the Hyponatremia Registry.
    Sigal SH; Amin A; Chiodo JA; Sanyal A
    Can J Gastroenterol Hepatol; 2018; 2018():1579508. PubMed ID: 30363747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An economic analysis of tolvaptan compared with fluid restriction among hospitalized patients with hyponatremia.
    Ramamohan V; Mladsi D; Ronquest N; Kamat S; Boklage S
    Hosp Pract (1995); 2017 Aug; 45(3):111-117. PubMed ID: 28449624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, double blinded, placebo-controlled trial to evaluate the efficacy and safety of tolvaptan in Chinese patients with hyponatremia caused by SIADH.
    Chen S; Zhao JJ; Tong NW; Guo XH; Qiu MC; Yang GY; Liu ZM; Ma JH; Zhang ZW; Gu F
    J Clin Pharmacol; 2014 Dec; 54(12):1362-7. PubMed ID: 24906029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertonic saline for hyponatremia: risk of inadvertent overcorrection.
    Mohmand HK; Issa D; Ahmad Z; Cappuccio JD; Kouides RW; Sterns RH
    Clin J Am Soc Nephrol; 2007 Nov; 2(6):1110-7. PubMed ID: 17913972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited Efficacy of Tolvaptan in Patients with Cirrhosis and Severe Hyponatremia: Real-Life Experience.
    Pose E; Solà E; Piano S; Gola E; Graupera I; Guevara M; Cárdenas A; Angeli P; Ginès P
    Am J Med; 2017 Mar; 130(3):372-375. PubMed ID: 27746291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between the Serum Sodium Levels and the Response to Tolvaptan in Liver Cirrhosis Patients with Ascites and Hyponatremia.
    Hayashi M; Abe K; Fujita M; Okai K; Takahashi A; Ohira H
    Intern Med; 2018 Sep; 57(17):2451-2458. PubMed ID: 29607963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolvaptan and Neurocognitive Function in Mild to Moderate Chronic Hyponatremia: A Randomized Trial (INSIGHT).
    Verbalis JG; Ellison H; Hobart M; Krasa H; Ouyang J; Czerwiec FS;
    Am J Kidney Dis; 2016 Jun; 67(6):893-901. PubMed ID: 26874645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertonic saline and desmopressin: a simple strategy for safe correction of severe hyponatremia.
    Sood L; Sterns RH; Hix JK; Silver SM; Chen L
    Am J Kidney Dis; 2013 Apr; 61(4):571-8. PubMed ID: 23266328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of tolvaptan in patients hospitalized for worsening chronic heart failure with severe hyponatremia: The initial experience at a single-center in Turkey.
    Sağ S; Aydın Kaderli A; Yıldız A; Gül BC; Özdemir B; Baran İ; Güllülü S; Aydınlar A; Çavuşoğlu Y
    Turk Kardiyol Dern Ars; 2017 Jul; 45(5):415-425. PubMed ID: 28694395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasopressin v(2) receptor blockade with tolvaptan versus fluid restriction in the treatment of hyponatremia.
    Gheorghiade M; Gottlieb SS; Udelson JE; Konstam MA; Czerwiec F; Ouyang J; Orlandi C;
    Am J Cardiol; 2006 Apr; 97(7):1064-7. PubMed ID: 16563917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic impact of tolvaptan treatment vs. fluid restriction based on real-world data among hospitalized patients with heart failure and hyponatremia.
    Dasta JF; Sundar S; Chase S; Lingohr-Smith M; Lin J
    Hosp Pract (1995); 2018 Oct; 46(4):197-202. PubMed ID: 30045645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Outcome of Cirrhotic Patients with Ascites Is Improved by the Normalization of the Serum Sodium Level by Tolvaptan.
    Kogiso T; Kobayashi M; Yamamoto K; Ikarashi Y; Kodama K; Taniai M; Torii N; Hashimoto E; Tokushige K
    Intern Med; 2017 Nov; 56(22):2993-3001. PubMed ID: 28943585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyponatremia: a problem-solving approach to clinical cases.
    Assadi F
    J Nephrol; 2012; 25(4):473-80. PubMed ID: 22307436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minocycline prevents osmotic demyelination associated with aquaresis.
    Takagi H; Sugimura Y; Suzuki H; Iwama S; Izumida H; Fujisawa H; Ogawa K; Nakashima K; Ochiai H; Takeuchi S; Kiyota A; Suga H; Goto M; Banno R; Arima H; Oiso Y
    Kidney Int; 2014 Nov; 86(5):954-64. PubMed ID: 24759153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.